SEC Form 3 · accession 0001209191-16-133347

Audentes Therapeutics, Inc. · BOLD

Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗

Reporting owners

Versant Ventures IV, LLC

10% Owner

Versant Venture Capital IV, L.P.

10% Owner

Versant Side Fund IV, L.P.

10% Owner

Period of report

Jul 19, 2016

Accepted (ET)

Jul 19, 2016 · 5:21 pm EDT

Rule 10b5-1 plan

unknown — predates the checkbox

Issuer CIK

0001628738

Table I — non-derivative securities

Security	Date	Code	Shares	Price	A/D	Owned after	D/I	Nature of ownership
No securities beneficially held	holding	—	—		—	0	D

Table II — derivative securities

Security	Conv. / exercise price	Date	Code	Shares	A/D	Exercisable	Expires	Underlying	Underlying shares	Owned after	D/I
Series A Preferred Stock^F2,F3,F1	—	holding	—	—	—	—	—	Common Stock	1,081,477	—	I
Series B Preferred Stock^F2,F3,F4	—	holding	—	—	—	—	—	Common Stock	480,856	—	I
Series C Preferred Stock^F2,F3,F5	—	holding	—	—	—	—	—	Common Stock	198,410	—	I
Series A Preferred Stock^F6,F7,F1	—	holding	—	—	—	—	—	Common Stock	6,811	—	I
Series B Preferred Stock^F6,F7,F4	—	holding	—	—	—	—	—	Common Stock	3,029	—	I
Series C Preferred Stock^F6,F7,F5	—	holding	—	—	—	—	—	Common Stock	1,249	—	I

Explanation of responses

F1Each share of the issuer's Series A Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the issuer's IPO and has no expiration date.
F2Versant Ventures IV, LLC ("VV IV") is the general partner of Versant Venture Capital IV, L.P. ("VVC IV"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F3Each of Thomas Woiwode, a member of the issuer's board of directors, Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden is a managing member of VV IV and may be deemed to share voting and dispositive power over the securities held by VVC IV. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F4Each share of the issuer's Series B Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the issuer's IPO and has no expiration date.
F5Each share of the issuer's Series C Preferred Stock will automatically convert into 1 share of the issuer's Common Stock immediately upon the closing of the issuer's IPO and has no expiration date.
F6VV IV is the general partner of Versant Side Fund IV, L.P. ("VSF IV"), the record holder of the securities, and disclaims beneficial ownership over such securities except to the extent of its pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.
F7Each of Thomas Woiwode, a member of the issuer's board of directors, Brian Atwood, Bradley Bolzon, Samuel Colella, Ross Jaffe, William Link, Kirk Nielsen, Robin Praeger, Rebecca Robertson and Charles Warden is a managing member of VV IV and may be deemed to share voting and dispositive power over the securities held by VSF IV. Each of such individuals disclaims beneficial ownership over such securities except to the extent of his or her pecuniary interest therein, and the inclusion of these securities in this report shall not be deemed an admission of beneficial ownership of the reported securities for purposes of Section 16 or for any other purposes.